Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tommysdad who wrote (4137)	4/24/1998 2:43:00 PM
From: Steve Fancy	of 6136

Agouron doesn't seem to believe in press releases. I didn't realize this either. Latest I saw was in PW's report on earnings. >>-- MMP Inhibitor or AG3340 for cancer: Two pivotal Phase II clinical studies have been initiated in combination with current chemotherapeutics to treat non-small lung cancer and hormone refractory prostate cancer. We believe the market launch for the product is likely to occur in 2001 with the potential to be a multi-hundred million dollar product.<< >>Clinical results of Phase I/II dose ranging studies for MMP inhibitor (AG3340) -- mid-1998<< I don't know why they are so opposed to let the world know what's going on. Somehow doesn't leave a great feeling regarding results. I'm glad to hear progress is being made. sf

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next